Implementing a Standardized Pharmacist Assessment and Evaluating the Role of a Pharmacist in a Multidisciplinary Supportive Oncology Clinic

Journal of Supportive Oncology

Volumn 10, Issue 3, 2012, Pages 99-106

  Mancini, Robert ^a  

^a The Lead Pharmacist in the Oral Chemotherapy Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; HISTAMINE H2 RECEPTOR ANTAGONIST; METOCLOPRAMIDE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SEROTONIN 3 ANTAGONIST; WARFARIN;

ARTICLE; BREAKTHROUGH PAIN; CANCER CENTER; CANCER FATIGUE; CANCER PALLIATIVE THERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CONSTIPATION; HEALTH CARE ACCESS; HUMAN; MEDICATION THERAPY MANAGEMENT; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACIST; POLYPHARMACY; UNITED STATES;

AMBULATORY CARE FACILITIES; HEALTH PLAN IMPLEMENTATION; HUMANS; MEDICAL ONCOLOGY; MEDICATION THERAPY MANAGEMENT; PATIENT CARE TEAM; PHARMACEUTICAL SERVICES; PROFESSIONAL ROLE; QUALITY OF HEALTH CARE;

EID: 84860616754     PISSN: 15446794     EISSN: 1879596X     Source Type: Journal    
DOI: 10.1016/j.suponc.2011.09.005     Document Type: Article

References (24)

1. Yennurajalingam S., Urbauer D.L., Casper K.L.B., et al. Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage 2010 Aug 24, Epub ahead of print.
2. Bruera E., Hui D. Integrating supportive and palliative care in the trajectory of cancer: establishing goals and models of care. J Clin Oncol 2010, 28(25):4013-4017.
3. Hui D., Elsayem A., De La Cruz M., et al. Availability and integration of palliative care at US cancer centers. JAMA 2010, 303(11):1054-1061.
4. Jacobsen J., Jackson V., Dahlin C., et al. Components of early outpatient palliative care consultation in patients with metastatic nonsmall cell lung cancer. J Palliat Med 2001, 14(4):459-464.
5. Pituskin E., Fairchild A., Dutka J., et al. Multidisciplinary team contributions within a dedicated outpatient palliative radiotherapy clinic: a prospective descriptive study. Int J Radiat Oncol Biol Phys 2010, 78(2):527-532.
6. Strasser F., Sweeney C., Willey J., et al. Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study. J Pain Symptom Manage 2004, 27(6):481-491.
7. Whitmer K., Pruemer J., Wilhelm C., et al. Development of an outpatient oncology symptom management clinic. J Clin Oncol Nurs 2011, 15(2):175-179.
8. Folwell M., Burman D., Le L.W., et al. Phase II study of an outpatient palliative care intervention in patients with metastatic cancer. J Clin Oncol 2009, 27(2):206-213.
9. Temel J.S., Greer J.A., Muzikansky A., et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010, 363:733-742.
10. Muir J.C., Daly F., Davis M.S., et al. Integrating palliative care into the outpatient, private practice setting. J Pain Symptom Manage 2010, 40:126-135.
11. Bruera E., Michaud M., Vigano A., et al. Multidisciplinary symptom control clinic in a cancer center: a retrospective study. Support Care Cancer 2001, 9:162-168.
12. Bakitas M., Lyons K.D., Hegel M.T., et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the project ENABLE II randomized controlled trial. JAMA 2009, 302(7):741-749.
13. Griffith J., Lyman J.A., Blackhall L.J. Providing palliative care in the ambulatory care setting. Clin J Oncol Nurs 2010, 14(2):171-175.
14. Atayee R.S., Best B.M., Daniels C.E. Development of an ambulatory palliative care pharmacist practice. J Palliat Med 2008, 11(8):1077-1082.
15. Mintzer D.M., Granda-Cameron C., Tobin B., et al. Embedding palliative care and geriatric oncology within a private oncology practice: one model for success. Commun Oncol 2009, 6:331-334.
16. Kleithermes M.A., Schullo-Feulner A.M., Tilton J., et al. Model for medication therapy management in a university clinic. Am J Health-Syst Pharm 2008, 65:844-856.
17. National Comprehensive Cancer Network Guidelines. Palliative care. V.2.2011. NCCN Guidelines http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
18. National Comprehensive Cancer Network Guidelines. Cancer-related fatigue. V.1.2011. NCCN Guidelines http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
19. ® oral tablets, metoclopramide oral tablets. Package insert 2009, Alaven Pharmaceutical, Alaven Pharmaceutical, Marietta, GA.
20. Riechelmann R.P., Del Giglio A. Drug Interactions in oncology: how common are they?. Ann Oncol 2009, 20(12):1907-1912.
21. Reichelmann R.P., Zimmermann C., Chin S.N., et al. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage 2008, 35(5):535-543.
22. Wilcock A., Thomas J., Frisby J., et al. Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centers: a multicentre audit. Br J Clin Pharmacol 2005, 60(3):326-329.
23. Riechelmann R.P., Tannock I.F., Wang L., et al. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst 2007, 99(8):592-600.
24. Riechelmann R.P., Krzyzanowska M.K., O'Carroll A., Zimmermann C. Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer 2007, 15(12):1407-1412.